Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tiziana Life Sciences Ltd (NQ: TLSA ) 0.9100 +0.0100 (+1.11%) Streaming Delayed Price Updated: 3:59 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 229,067 Open 0.8800 Bid (Size) 0.9100 (2) Ask (Size) 0.9500 (20) Prev. Close 0.9000 Today's Range 0.8772 - 0.9500 52wk Range 0.4100 - 1.740 Shares Outstanding 194,612,289 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus November 06, 2024 Tesla stock is set to hit a 15-month high. Via Investor's Business Daily Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See" November 05, 2024 Tesla stock flashed a sell signal Monday and is well below a traditional buy point. Via Investor's Business Daily Performance YTD +59.62% +59.62% 1 Month -1.30% -1.30% 3 Month -35.00% -35.00% 6 Month +36.15% +36.15% 1 Year +44.44% +44.44% More News Read More Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data November 01, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million October 30, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study October 30, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session October 18, 2024 Via Benzinga Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building October 10, 2024 Via Benzinga Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease September 19, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Appoints New Chief Executive Officer August 19, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule August 14, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire The 3 Best EV Stocks to Buy in August 2024 August 10, 2024 Via InvestorPlace Tiziana Life Sciences Granted FDA Fast Track Designation July 24, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Receives $3.4 Million in Non-Dilutive Funding June 28, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding June 28, 2024 Via News Direct Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab June 26, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session June 17, 2024 Via Benzinga FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis June 11, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises June 11, 2024 Via FinancialNewsMedia Exposures Product Safety 12 Health Care Stocks Moving In Friday's After-Market Session June 07, 2024 Via Benzinga Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab June 06, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises June 11, 2024 From FN Media Group LLC Via GlobeNewswire Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab June 04, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research May 30, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert May 15, 2024 Via Benzinga Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab May 13, 2024 From Tiziana Life Sciences Ltd. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
